Bicocca Open Archive

Logo unimib boa
CORDANI, NICOLETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.802
AS - Asia 3.496
EU - Europa 2.755
SA - Sud America 467
AF - Africa 68
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
Totale 11.600
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.577
SG - Singapore 1.097
IT - Italia 1.052
CN - Cina 755
VN - Vietnam 604
HK - Hong Kong 427
RU - Federazione Russa 361
BR - Brasile 345
DE - Germania 241
SE - Svezia 208
IE - Irlanda 199
CA - Canada 174
FR - Francia 148
IN - India 134
GB - Regno Unito 127
UA - Ucraina 101
KR - Corea 81
ID - Indonesia 67
FI - Finlandia 61
BD - Bangladesh 51
NL - Olanda 49
TR - Turchia 45
ES - Italia 44
AR - Argentina 42
JP - Giappone 42
PL - Polonia 40
IQ - Iraq 38
MX - Messico 30
AT - Austria 27
PK - Pakistan 26
ZA - Sudafrica 25
CH - Svizzera 24
SA - Arabia Saudita 21
VE - Venezuela 19
EC - Ecuador 18
PH - Filippine 17
CO - Colombia 16
UZ - Uzbekistan 15
DK - Danimarca 14
BE - Belgio 12
LT - Lituania 12
JO - Giordania 10
AE - Emirati Arabi Uniti 9
CL - Cile 9
KE - Kenya 9
MA - Marocco 9
AL - Albania 8
AU - Australia 7
EG - Egitto 6
MY - Malesia 6
PE - Perù 6
TH - Thailandia 6
BO - Bolivia 5
IR - Iran 5
KZ - Kazakistan 5
NP - Nepal 5
PS - Palestinian Territory 5
BG - Bulgaria 4
DO - Repubblica Dominicana 4
EU - Europa 4
JM - Giamaica 4
LB - Libano 4
MT - Malta 4
OM - Oman 4
RO - Romania 4
GR - Grecia 3
MU - Mauritius 3
PY - Paraguay 3
SV - El Salvador 3
TN - Tunisia 3
UY - Uruguay 3
BB - Barbados 2
BY - Bielorussia 2
CR - Costa Rica 2
CY - Cipro 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
ET - Etiopia 2
KG - Kirghizistan 2
KW - Kuwait 2
LV - Lettonia 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TW - Taiwan 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
DM - Dominica 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
KH - Cambogia 1
LC - Santa Lucia 1
LY - Libia 1
MG - Madagascar 1
Totale 11.589
Salva come PNG Salva come JPEG
Città #
Singapore 639
Ann Arbor 574
Ashburn 501
Milan 402
Hong Kong 401
San Jose 382
Dallas 260
Woodbridge 219
Chandler 203
Dublin 193
Hanoi 179
New York 175
Fairfield 168
Houston 154
Ho Chi Minh City 153
Hefei 150
Frankfurt am Main 137
Los Angeles 131
Wilmington 109
Toronto 105
Beijing 96
Jacksonville 93
Seattle 83
Santa Clara 80
Seoul 78
Chicago 73
Dearborn 69
The Dalles 68
Cambridge 62
Jakarta 55
Council Bluffs 51
São Paulo 46
Buffalo 43
Rome 42
Lauterbourg 40
Shanghai 40
Moscow 38
Princeton 38
Nanjing 37
Desio 35
Da Nang 33
Orem 32
Munich 30
Tokyo 29
Lissone 27
London 26
Warsaw 25
Helsinki 24
Montreal 24
Zurich 23
Denver 21
Nuremberg 20
Poplar 20
Baghdad 19
Mumbai 19
Paris 19
Phoenix 19
Stockholm 19
Atlanta 18
Boardman 18
Chennai 17
Haiphong 17
Lawrence 17
Brooklyn 16
Kent 16
Seveso 16
Lachine 15
Monza 15
Pune 14
Rio de Janeiro 14
Vienna 14
Amsterdam 13
Ankara 12
Brussels 12
Carate Brianza 12
Genoa 12
Hải Dương 12
Johannesburg 12
Nanchang 12
Salt Lake City 12
Biên Hòa 11
Bắc Ninh 11
San Diego 11
Tashkent 11
Turku 11
Altamura 10
Can Tho 10
Cinisello Balsamo 10
Lappeenranta 10
Ottawa 10
Riyadh 10
Shenyang 10
Tianjin 10
Manchester 9
Seregno 9
Boston 8
Ha Long 8
Hangzhou 8
Nairobi 8
Quận Bình Thạnh 8
Totale 7.340
Salva come PNG Salva come JPEG
Nome #
Lorlatinib treatment elicits multiple on- and off-target mechanisms of resistance in ALK-driven cancer 525
OncoScore: A novel, Internet-based tool to assess the oncogenic potential of genes 455
Loss of CDKN2B expression as a potential marker of resistance to CDK4/6 inhibitor in Luminal Breast Cancer cells 424
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 415
A Compound L1196M/G1202R ALK Mutation in a Patient with ALK-Positive Lung Cancer with Acquired Resistance to Brigatinib Also Confers Primary Resistance to Lorlatinib 396
Erratum: OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes 392
CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON? 354
TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells 349
Baseline 18FDG-PET Metabolic Tumour Volume (MTV) as a Potential Predictive Factor of Response to Metronomic Chemotherapy (mCHT) in HR+/HER2- Metastatic Breast Cancer (MBC) Patients (pts). Preliminary Results of the Metro-pet Study 345
Primary cell cultures arising from normal kidney and renal cell carcinoma retain the proteomic profile of corresponding tissues 337
Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC) 332
Chronic myeloid leukemia: Second-line drugs of choice 328
Expression of heat shock protein 27 in human renal cell carcinoma 326
Characterization of heat shock protein 27 phosphorylation sites in renal cell carcinoma 322
Differential Expression of NOTCH-1 and Its Molecular Targets in Response to Metronomic Followed by Conventional Therapy in a Patient with Advanced Triple-Negative Breast Cancer 307
Isolation of FAP Cells from Mouse Dystrophic Skeletal Muscle Using Fluorescence Activated Cell Sorting 303
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients 282
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 279
Mutant p53 subverts p63 control over KLF4 expression in keratinocytes 264
An Overview of PARP Resistance in Ovarian Cancer from a Molecular and Clinical Perspective 261
Comparative proteomics of membrane microdomains from renal cell carcinoma and adiacent normal kidney 259
Comprehensive analysis of mutational processes across 20 000 adult and pediatric tumors 252
Proteolysis Targeting Chimera Agents (PROTACs): New Hope for Overcoming the Resistance Mechanisms in Oncogene-Addicted Non-Small Cell Lung Cancer 251
Prognostic Biomarkers in Breast Cancer via Multi-Omics Clustering Analysis 245
Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation 237
Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy 234
Nitric Oxide Controls Fat Deposition in Dystrophic Skeletal Muscle by Regulating Fibro-Adipogenic Precursor Differentiation 223
Malignant fibrous histiocytoma: a proposed cellular origin and identification of its characterizing gene transcripts 223
Cisplatin may be a valid alternative approach in ovarian carcinoma with carboplatin hypersensitivity. Report of three cases 212
Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: final results of the exploratory phase 2 Victor-5 study 209
How to Treat HR+/HER2-Metastatic Breast Cancer Patients after CDK4/6 Inhibitors: An Unfinished Story 206
Edaravone: A Novel Possible Drug for Cancer Treatment? 202
Metronomic Chemotherapy for Metastatic Breast Cancer Treatment: Clinical and Preclinical Data between Lights and Shadows 198
Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer 195
A Phase 2, Open Label, Multicenter, Single Arm Trial Evaluating the Activity and Safety of Abemaciclib + Aromatase Inhibitors (AIs) as Second-Line Treatment After First-Line Fulvestrant in Hormone-Receptor-Positive (HR+), Human-Epidermal-Growth-Factor-Receptor-Negative (HER2-) Metastatic Breast Cancer (MBC) Patients. Final Results of HERMIONE-7 Trial 188
Abstract 987: Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy 187
Expression of endothelial protein C receptor and thrombomodulin in the intestinal tissue of patients with inflammatory bowel disease 183
The relative endogenous expression levels of the IFNAR2 isoforms influence the cytostatic and pro-apoptotic effect of IFN alpha on pleomorphic sarcoma cells 181
Harnessing DLL3 inhibition: From old promises to new therapeutic horizons 176
Derangement of endothelial protein C receptor and thrombomodulin expression in the intestinal mucosa of patients with inflammatory bowel diseases 176
Metronomic chemotherapy 169
EGFR overexpression in malignant pleural mesothelioma: An immunohistochemical and molecular study with clinico-pathological correlations 165
Investigation of the origin of malignant fibrous histiocytoma and identification of specific predictive markers for this tumour 150
Author Correction: Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer (npj Precision Oncology, (2025), 9, 1, (291), 10.1038/s41698-025-01088-0) 105
Totale 11.822
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.530
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.530
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202189 0 0 0 0 0 0 0 0 0 0 36 53
2021/2022293 30 42 48 32 8 21 13 15 11 19 21 33
2022/2023763 48 200 39 91 46 72 43 40 36 64 48 36
2023/2024906 50 50 32 51 115 187 146 40 53 39 41 102
2024/20252.210 121 181 147 120 191 88 140 56 224 321 188 433
2025/20265.606 652 498 528 709 669 284 905 242 407 490 222 0
Totale 11.822